|KIST Europe and KCL signed MoU Oct-07-2022|
On Sep 27 2022, the Korea Conformity Laboratories and KIST Europe signed the 2. Memorandum of Understanding to develop and to concretize their intention to enhance of mutual common interest through global regulation on the bio-research and data sharing about AOP (Adverse Outcome Pathways).
The agreement for cooperation includes promoting joint research collaboration, including on-site Laborotiry at KIST Europe.
The Memorandum of Understanding was signed by Yung Tae Jo, President of the Korea Conformity Laboratories, and Dr. Soo Hyun Kim, Institute Director of KIST Europe.
|Prev||Delegation from KEIT visited KIST Europe|
|Next||KOSDAQ Executives visited KIST Europe|